Skin Cancer/Melanoma

Melanoma: Testing for Immunotherapy-Related Hepatotoxicity
Melanoma: Testing for Immunotherapy-Related Hepatotoxicity
BY MICHAEL B. ATKINS, MD, AND KELLIE GARDNER, NP
Managing Gastrointestinal Toxicities in Melanoma
Managing Gastrointestinal Toxicities in Melanoma
BY MICHAEL A. POSTOW, MD, AND CLAIRE CROWLEY, RN
Melanoma: Management of Dermatologic Toxicities
Melanoma: Management of Dermatologic Toxicities
BY MICHAEL B. ATKINS, MD, AND KELLIE GARDNER, NP
Overall Toxicities With Immunotherapy in Melanoma
Overall Toxicities With Immunotherapy in Melanoma
BY MICHAEL A. POSTOW, MD, AND CLAIRE CROWLEY, RN
Monotherapy Versus Combination Therapy Approaches in Melanoma
Monotherapy Versus Combination Therapy Approaches in Melanoma
BY MICHAEL A. POSTOW, MD, AND MICHAEL B. ATKINS, MD
Melanoma: Speed and Durability of Therapeutic Response
Melanoma: Speed and Durability of Therapeutic Response
BY MICHAEL A. POSTOW, MD, AND MICHAEL B. ATKINS, MD
BRAF-Mutant Melanoma: Frontline Decisions
BRAF-Mutant Melanoma: Frontline Decisions
BY MICHAEL B. ATKINS, MD, AND MICHAEL A. POSTOW, MD
Immunotherapy in BRAF Wild-Type Melanoma
Immunotherapy in BRAF Wild-Type Melanoma
BY MICHAEL B. ATKINS, MD, AND MICHAEL POSTOW, MD
Initial Treatment Approach in Advanced Melanoma: Factors to Consider
Initial Treatment Approach in Advanced Melanoma: Factors to Consider
BY MICHAEL B. ATKINS, MD, AND MICHAEL POSTOW, MD
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.